Summit Congresses / 2024

2024 World Congress on Lung Cancer (WCLC)

Visit Summit: Booth #2900
September 7-10, 2024
San Diego, CA USA
Summit WCLC Press Release August 12, 2024

PL02. Presidential Symposium 1
September 8, 2024
8:37 – 8:44 AM (PDT/UTC-7)
PL02.04 Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: Primary Analysis of HARMONi-2
Caicun Zhou, MD. Ph.D
WCLC24 Schedule (PL02)

OA01. Perioperative Strategies 1
September 8, 2024
11:17 – 11:27 AM (PDT/UTC-7)
OA01.06A. Phase II Study of Perioperative Ivonescimab Alone or Combined with Chemotherapy in Resectable Non-Small Cell Lung Cancer
Caicun Zhou, MD. Ph.D
WCLC24 Schedule (OA01)

Meet with Drs. Yang and West During These Dedicated Times:

Sunday, Sept. 8th
1:00 – 3:00pm

Allen S. Yang, MD, Ph.D.
Chief Medical Officer Former Academic Oncologist, Over 100 Peer-reviewed Publications

Sunday, Sept. 8th
12:30 – 1:30pm

Monday, Sept. 9th
1:00 – 2:00pm

Tuesday, Sept. 10th
10:00 – 11:00am

H. Jack West, MD
Vice President of Clinical Development
Oncologist & Lung Cancer Expert

ESMO Congress 2024

Visit Summit: Booth #431
September 13-17, 2024
Barcelona, Spain

Ivonescimab Poster Presentation
September 14, 2024
12:00 – 1:00pm (CEST UTC+2)
876P – Evaluation of the safety and efficacy of ivonescimab in combination with ligufalimab as first-line (1L) treatment for PD-L1 positive recurrent/metastasis head and neck squamous cell carcinoma (R/M HNSCC)

Ivonescimab Mini-Oral Presentation
September 16, 2024
8:30 – 8:35am (CEST UTC+2)
347MO – The safety and efficacy of ivonescimab in combination with chemotherapy as first-line (1L) treatment for triple-negative breast cancer (TNBC)

Ivonescimab Poster Presentation
September 16, 2024
12:00 – 1:00pm (CEST UTC+2)
514P – The efficacy and safety of ivonescimab with or without ligufalimab in combination with FOLFOXIRI as first-line (1L) treatment for metastatic colorectal cancer (mCRC)

Meet with Dr. West During These Dedicated Times:

Friday, Sept. 13th
3:00 – 4:00pm

Saturday, Sept. 14th
10:30 – 11:30am

Sunday, Sept. 15th
9:00 – 10:00am

Monday, Sept. 16th
1:30 – 2:30pm

H. Jack West, MD
Vice President of Clinical Development
Oncologist & Lung Cancer Expert

To schedule an appointment or for more information please contact:
medinfo@smmttx.com
investors@smmttx.com